NFE2L2 and amyotrophic lateral sclerosis: CAPE was also able to activate the Nrf2–ARE pathway (Figs. 7c and d), a pathway we have previously shown to be down-regulated in NSC34 cells expressing mutant SOD1 and MNs isolated from cases of familial SOD1-associated ALS [52].